| Q41043511 | Accelerated oxygen-induced retinopathy is a reliable model of ischemia-induced retinal neovascularization |
| Q28509077 | CYP1B1 and endothelial nitric oxide synthase combine to sustain proangiogenic functions of endothelial cells under hyperoxic stress |
| Q35348072 | Deletion of thioredoxin interacting protein (TXNIP) augments hyperoxia-induced vaso-obliteration in a mouse model of oxygen induced-retinopathy. |
| Q36489211 | Endothelial nitric oxide synthase gene T-786C and 27-bp repeat gene polymorphisms in retinopathy of prematurity. |
| Q43942057 | Epidemiology and pathophysiology of retinopathy of prematurity |
| Q48095108 | Ischemic Retinopathies: Oxidative Stress and Inflammation. |
| Q48361049 | Lysophosphatidic acid induces endothelial cell death by modulating the redox environment. |
| Q36044670 | MEF2C ablation in endothelial cells reduces retinal vessel loss and suppresses pathologic retinal neovascularization in oxygen-induced retinopathy |
| Q36761991 | Neutralizing VEGF decreases tortuosity and alters endothelial cell division orientation in arterioles and veins in a rat model of ROP: relevance to plus disease |
| Q34580309 | Novel peptide for attenuation of hyperoxia-induced disruption of lung endothelial barrier and pulmonary edema via modulating peroxynitrite formation |
| Q48715740 | Overexpression of extracellular superoxide dismutase has a protective role against hyperoxia-induced brain injury in neonatal mice. |
| Q43221726 | Oxygen-induced retinopathy: a model for vascular pathology in the retina. |
| Q29615424 | Peroxynitrite: biochemistry, pathophysiology and development of therapeutics |
| Q64249029 | Propranolol 0.2% Eye Micro-Drops for Retinopathy of Prematurity: A Prospective Phase IIB Study |
| Q92106562 | Redox Regulation of the Microcirculation |
| Q41494887 | Retinopathy of prematurity: inflammation, choroidal degeneration, and novel promising therapeutic strategies |
| Q34090125 | Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life |
| Q38952692 | Review of the mechanisms and therapeutic avenues for retinal and choroidal vascular dysfunctions in retinopathy of prematurity. |
| Q42081421 | Signaling pathways triggered by oxidative stress that mediate features of severe retinopathy of prematurity |
| Q46509676 | Stimulation of peroxynitrite catalysis improves insulin sensitivity in high fat diet-fed mice |
| Q43113001 | Sustained hypercapnia induces cerebral microvascular degeneration in the immature brain through induction of nitrative stress |
| Q36700111 | Targets of vascular protection in acute ischemic stroke differ in type 2 diabetes |
| Q37165257 | The effect of oxygen and light on the structure and function of the neonatal rat retina. |
| Q30495106 | The mouse retina as an angiogenesis model |
| Q42782088 | Thioredoxin-interacting protein expression is required for VEGF-mediated angiogenic signal in endothelial cells. |
| Q36849847 | Trans-arachidonic acids generated during nitrative stress induce a thrombospondin-1-dependent microvascular degeneration |
| Q37625883 | Understanding ischemic retinopathies: emerging concepts from oxygen-induced retinopathy. |
| Q34038976 | Understanding retinopathy of prematurity: update on pathogenesis |
| Q93103382 | Vascular and Neuronal Protection in the Developing Retina: Potential Therapeutic Targets for Retinopathy of Prematurity |